Found 8 matching trials
Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon PHASE1 LA rVSVΔG-ZEBOV-GP -02-PED is a Phase 1/2, randomized, controlled open labe...
Show More Location
Centre de Recherches Médicales de Lambaréné
Learn More & Join Trial
African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola PHASE2 This is a randomized, placebo-controlled, multi-site, double-blind trial of...
Show More Learn More & Join Trial
Partnership for Research on Ebola VACcinations PHASE2 The purpose of this study is to evaluate the safety and immunogenicity of t...
Show More Location
Centre national de formation et de recherche en santé rurale (Maferyniah)
Learn More & Join Trial
Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) PHASE1 This is a study of the anti-Ebola vaccine vesicular stomatitis virus (VSV) ...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP Vaccine) PHASE2 Background:
The Ebola virus causes a severe disease that can be fatal. The...
Show More Location
The Hope Clinic of the Emory Vaccine Center, Emory University
Learn More & Join Trial
Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) PHASE3 The study evaluated the safety and immunogenicity of 3 consistency lots and...
Show More Location
Multiple Locations
Learn More & Join Trial
Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004) PHASE1 Ebola virus has infected and killed people, mostly in Africa. In 2014, the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002) PHASE1 Ebola virus has infected and killed people, mostly in Africa. In 2014, the ...
Show More Location
Multiple Locations
Learn More & Join Trial